bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. (BIAF) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 113 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jul 1, 2024 involved a transaction of 33,784 shares valued at $0.
BIAF Insider Activity Summary
Who Is Buying BIAF Stock?
No significant insider buying has been recorded for BIAF in the recent period.
Who Is Selling BIAF Stock?
No significant insider selling has been recorded for BIAF in the recent period.
Is bioAffinity Technologies, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BIAF is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
BIAF Frequently Asked Questions
Understanding BIAF Insider Activity
Insider trading at bioAffinity Technologies, Inc. (BIAF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading BIAF stock, having executed 113 transactions in the past 90 days. The most active insider is Sandler Revocable Trust Harvey (Executive), who has made 12 transactions totaling $3.5M.
Related Tools
Track bioAffinity Technologies, Inc. Insider Activity
Get notified when executives and directors at BIAF file new Form 4 transactions